BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10821852)

  • 1. SOCS-3 is an insulin-induced negative regulator of insulin signaling.
    Emanuelli B; Peraldi P; Filloux C; Sawka-Verhelle D; Hilton D; Van Obberghen E
    J Biol Chem; 2000 May; 275(21):15985-91. PubMed ID: 10821852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
    Ram PA; Waxman DJ
    J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*.
    Sadowski CL; Choi TS; Le M; Wheeler TT; Wang LH; Sadowski HB
    J Biol Chem; 2001 Jun; 276(23):20703-10. PubMed ID: 11279166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.
    Peraldi P; Filloux C; Emanuelli B; Hilton DJ; Van Obberghen E
    J Biol Chem; 2001 Jul; 276(27):24614-20. PubMed ID: 11325969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
    Ram PA; Waxman DJ
    J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver.
    Davey HW; McLachlan MJ; Wilkins RJ; Hilton DJ; Adams TE
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):111-6. PubMed ID: 10630411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.
    Emanuelli B; Peraldi P; Filloux C; Chavey C; Freidinger K; Hilton DJ; Hotamisligil GS; Van Obberghen E
    J Biol Chem; 2001 Dec; 276(51):47944-9. PubMed ID: 11604392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
    Cacalano NA; Sanden D; Johnston JA
    Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoproterenol is a positive regulator of the suppressor of cytokine signaling-3 gene expression in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Lossner U; Paschke R
    J Endocrinol; 2002 Dec; 175(3):727-33. PubMed ID: 12475383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
    Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA
    Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
    Story DJ; Stephens JM
    Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells.
    Rønn SG; Hansen JA; Lindberg K; Karlsen AE; Billestrup N
    Mol Endocrinol; 2002 Sep; 16(9):2124-34. PubMed ID: 12198248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.
    Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R
    J Endocrinol; 2004 Apr; 181(1):129-38. PubMed ID: 15072573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of SOCS family members in EpoR signal transduction.
    Jegalian AG; Wu H
    J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.